88950318 - CYTOVALE

Information

• Trademark
• 88950318

• Source

• Serial Number

  88950318

• International Classifications

  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 44 - Medical services

• Filing Date

  June 05, 2020
  4 years ago

• Transaction Date

  August 20, 2024
  3 months ago

• Status Date

  December 11, 2023
  11 months ago

• Published for Opposition Date

  September 14, 2021
  3 years ago

• Location Date

  May 19, 2022
  2 years ago

• Status Code

  606

• Current Location

  DIVISIONAL UNIT

  Employee Name

  FOSDICK, GEOFFREY A

• Attorney Docket Number

  08134

  Attorney Name

  Holly Pranger

  Law Office Assigned Location Code

  M20

• Owners

  • CytoVale, Inc

Case File Statements

• GS0441: medical services; medical treatment of sepsis, cancer and immune-mediated diseases; medical analysis services in the fields of cytometry, oncology, and hematology
• GS0101: medical diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes, medical diagnostic apparatus for analyzing gene expression tests using bioinformatics and machine learning algorithms, medical diagnostic apparatus for analyzing gene expression tests, gene expression profiling assays, genetic information, protein biomarkers, clinical data and/or demographic information to aid treatment decisions; sample preparation devices in the nature of lyse wash assistant being automated sample preparation instruments capable of lysing, washing, mixing, and fixing samples that are then ready for analysis on a flow cytometer TQ-prep workstations for standardizing whole blood lysis for flow cytometric analysis and related recorded data management software sold as a unit; diagnostic test apparatus for medical use for analysis of gene expression, protein expression, metabolite expression, inflammation, immune- suppression, immune disorders; medical and diagnostic apparatus for medical use in analysis of gene expression tests, analysis of gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing clinical data, and/or analyzing demographic information; point of care medical devices, namely, polymerase chain reaction (pcr) testing equipment for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders; medical testing kits for cancer and other immune-mediated conditions; apparatus for diagnostic purposes, namely, medical diagnostic apparatus for testing for cancer and other immune-mediated conditions in the fields of oncology and hematology; ultraviolet visible and near infrared fluorescence analyzers for medical use and components therefor; imaging platforms, namely, medical imaging apparatus for imaging and analysis of cells and cell organelles, molecular diagnostics and imaging cytometry for medical use; medical apparatuses for the examination and analysis of proteins, peptides, antibodies and molecules for medical diagnostic use and components therefor; diagnostic apparatus for medical use, namely, computed tomography scanners, fluorescent microscope systems comprised of optical detection modalities, magnification objective for use in performing fluorescent antibody technique analysis and fluorescent protein technique analysis, automatic cell sorting systems comprised of single-cell analysis, optical detection modalities, electrical detection modalities, mechanical detection modalities for use in flow cytometry analysis and in fluorescence activated cell sorting; flow cytometers

Case File Event Statements

• 6/9/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/29/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/16/2020 - 4 years ago

  7 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 9/9/2020 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 9/15/2020 - 4 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/15/2020 - 4 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/15/2020 - 4 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/16/2020 - 4 years ago

  9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 9/16/2020 - 4 years ago

  8 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 2/11/2021 - 3 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/11/2021 - 3 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/12/2021 - 3 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/20/2021 - 3 years ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 2/20/2021 - 3 years ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR

• 2/20/2021 - 3 years ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 8/12/2021 - 3 years ago

  16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 8/12/2021 - 3 years ago

  19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 8/12/2021 - 3 years ago

  17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 8/12/2021 - 3 years ago

  18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 8/26/2021 - 3 years ago

  23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/12/2021 - 3 years ago

  20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/26/2021 - 3 years ago

  21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/26/2021 - 3 years ago

  22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/14/2021 - 3 years ago

  27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/14/2021 - 3 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/14/2021 - 3 years ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/14/2021 - 3 years ago

  26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/9/2021 - 3 years ago

  28 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 5/2/2022 - 2 years ago

  31 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 5/2/2022 - 2 years ago

  32 - DIVISIONAL REQUEST RECEIVED Type: DRRR

• 5/9/2022 - 2 years ago

  29 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 5/9/2022 - 2 years ago

  34 - SOU EXTENSION 1 FILED Type: EXT1

• 5/14/2022 - 2 years ago

  30 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 5/19/2022 - 2 years ago

  33 - DIVISIONAL PROCESSING COMPLETE Type: DPCC

• 5/19/2022 - 2 years ago

  35 - SOU EXTENSION 1 GRANTED Type: EX1G

• 5/20/2022 - 2 years ago

  36 - CORRECTED NOA E-MAILED Type: NOAC

• 11/2/2022 - 2 years ago

  39 - SOU EXTENSION 2 FILED Type: EXT2

• 5/20/2022 - 2 years ago

  37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 11/2/2022 - 2 years ago

  38 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 11/5/2022 - 2 years ago

  41 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 5/8/2023 - a year ago

  43 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 5/8/2023 - a year ago

  44 - SOU EXTENSION 3 FILED Type: EXT3

• 11/4/2022 - 2 years ago

  40 - SOU EXTENSION 2 GRANTED Type: EX2G

• 1/17/2023 - a year ago

  42 - ASSIGNED TO EXAMINER Type: DOCK

• 5/8/2023 - a year ago

  45 - SOU EXTENSION 3 GRANTED Type: EX3G

• 5/10/2023 - a year ago

  46 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/11/2023 - 11 months ago

  48 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 12/11/2023 - 11 months ago

  47 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6